NCT02122991

Brief Summary

Increased life expectancy in individuals with spinal cord injury (SCI) present clinicians with the challenge of managing the secondary complications of SCI with the chronic diseases common in an aging population. Cardiovascular disease, cerebral vascular disease, and cognitive dysfunction are among the primary challenges facing clinicians in the treatment of an aging population. Cognitive dysfunction has been reported in upwards of 60% of the SCI population, which have been primarily attributed to concomitant traumatic brain injury or pre-morbid conditions. Identifying possible modifiable risk factors which contribute to the increased prevalence of cognitive dysfunction in the SCI population is of significant clinical relevance and cardiovascular and cerebrovascular disorders have emerged as possible contributors to the cognitive disorders in the general population. These risk factors include: physical inactivity, chronically low or high blood pressure (BP), reduced blood flow to the brain, arterial stiffening, and impaired nervous system regulation of the cardiovascular system. These risk factors are particularly prominent in the SCI population as they represent a model of profound inactivity, have trouble regulating blood pressure, and suffer impaired cardiovascular regulation from their injury. In addition, we've recently reported deficits in blood flow to the brain at rest and during cognitive tests; with results being further impaired in SCI with chronically low blood pressure. Therefore the goals of this project are to determine the influence of cardiovascular and cerebral vascular responses at rest and during cognitive testing on test performance in 80 individuals with SCI compared to 50 age-matched non-SCI controls. All potential subjects will undergo a rigorous two-part screening process which consists of an initial screening via telephone and a detailed, in-person screening. Eligible subjects will be invited to participate in a 3 hour laboratory visit during which their arterial stiffness, blood pressure, heart rate, respiration rate and, blood flow to the brain will be monitored at rest and during a comprehensive series of cognitive tests. We hypothesize that blood pressure and cerebrovascular response to testing will account significantly for performance in cognitive testing that otherwise would have been attributable to SCI status.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
61

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jul 2013

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 1, 2013

Completed
Same day until next milestone

Study Start

First participant enrolled

July 1, 2013

Completed
10 months until next milestone

First Posted

Study publicly available on registry

April 25, 2014

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2017

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2017

Completed
Last Updated

February 19, 2018

Status Verified

February 1, 2018

Enrollment Period

4.1 years

First QC Date

July 1, 2013

Last Update Submit

February 15, 2018

Conditions

Keywords

spinal cord injuryautonomic dysreflexiabaroreceptor integritysympathetic integrityvagal integrityautonomic integrityarterial stiffnesscognitive functiontraumatic brain injurycerebral blood flow

Outcome Measures

Primary Outcomes (2)

  • Systolic Blood Pressure (mmHg)

    To determine change in systolic blood pressure from seated rest to seated cognitive testing in subjects with and without spinal cord injury.

    Up to 2 years

  • Performance on tests of information processing (WAIS-IV and Digit Span) and working memory (SDMT)

    To compere cognitive performance on tests of working memory and information processing in individuals with and without spinal cord injury.

    up to 2 years

Secondary Outcomes (1)

  • Cerebral Blood Flow Velocity (cm/second) from the middle cerebral arteries

    Up to 2 years

Study Arms (2)

Able-Bodied Controls

Subjects must be between the ages of 30 and 64 years old, be English-literate and able to provide informed consent. They must score at least 20/60 minimum acuity in their worst eye on the Snell Eye Exam, and score at least 22 on the Montreal Cognitive Assessment. Subjects MUST NOT HAVE: an acute illness or infection, history of stroke, recent illicit drug abuse (\<6 months), unstable/uncontrolled seizures, neurodegenerative disease, Severe Traumatic Brain Injury (as determined by TBI screening tool), any significant history of neurological disease/disorder, any significant systemic illness or unstable medical condition (uncontrolled diabetes, hypo- or hyperthyroidism, systemic cancer), history of schizophrenia or bipolar disorder or any active psychosis, or alcohol/substance abuse or dependence (\<6 months).

Spinal Cord Injury

Subjects must be between the age of 30 and 64 years old, be English-literate and able to provide informed consent. They must be at least 1 year from the date of their spinal cord injury. They must score at least 20/60 minimum acuity in their worst eye on the Snell Eye Exam, and score at least 22 on the Montreal Cognitive Assessment. Subjects MUST NOT HAVE: an acute illness or infection, history of stroke, recent illicit drug abuse (\<6 months), unstable/uncontrolled seizures, neurodegenerative disease, Severe Traumatic Brain Injury (as determined by TBI screening tool), any significant history of neurological disease/disorder, any significant systemic illness or unstable medical condition (uncontrolled diabetes, hypo- or hyperthyroidism, systemic cancer), history of schizophrenia or bipolar disorder or any active psychosis, or alcohol/substance abuse or dependence (\<6 months).

Eligibility Criteria

Age30 Years - 64 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

80 subjects with chronic SCI and 50 age-matched non-SCI controls will be recruited from out-patient clinics at the JJP VAMC and the Center of Excellence. This includes subjects who have completed various protocols in the Cardiovascular autonomic testing laboratory or patients referred by their physicians following routine physical examinations. Physicians will be informed of the inclusion and exclusion criteria for this study and will be able to provide us with the assurance that the patient is an appropriate candidate for the study and that he/she was willing to speak with the study coordinators.

You may qualify if:

  • Between the ages of 30 and 64 years old
  • If SCI, the duration of injury must be greater than 1 year
  • At least 20/60 minimum acuity in worst eye on the Snell Eye Exam
  • A score ≥22 on the Montreal Cognitive Assessment
  • English literate
  • Able to provide informed consent

You may not qualify if:

  • Acute illness or infection
  • Documented history of:
  • Stroke
  • Recent illicit drug abuse (from medical chart, within the past 6-months)
  • Unstable or uncontrolled seizures
  • Neurodegenerative disease including Alzheimer's disease, Parkinson's disease, Huntington's disease
  • Severe TBI (identified by TBI screening tool)
  • Any significant history of neurological disease/disorders:
  • Alzheimer's disease
  • Parkinson's disease
  • Vascular dementia
  • Huntington's disease
  • Pick's disease
  • Lewy Body Dementia
  • Frontotemporal dementia
  • +11 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

James J Peters VA Medical Center

The Bronx, New York, 10468, United States

Location

MeSH Terms

Conditions

Spinal Cord InjuriesAutonomic DysreflexiaBrain Injuries, Traumatic

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and InjuriesAutonomic Nervous System DiseasesBrain InjuriesBrain DiseasesCraniocerebral Trauma

Study Officials

  • Jill M Wecht, Ed.D.

    JJPVAMC

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
FED
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Health Scientist

Study Record Dates

First Submitted

July 1, 2013

First Posted

April 25, 2014

Study Start

July 1, 2013

Primary Completion

August 1, 2017

Study Completion

December 1, 2017

Last Updated

February 19, 2018

Record last verified: 2018-02

Locations